Number of patients treated. Effectivity, safety and cost-effectiveness of different treatment modalities, quality of life.
Conditions
Interventions
None listed
Sponsors
Dutch working party on non-malignant hematology of the Dutch Society of Hematology
Eligibility
Inclusion criteria
Inclusion criteria: Adult patients (M/F) with chronic or persistent ITP (with history of splenectomy) needing additional treatment (inc. wait-and-see patients qualifying for ITP but not activily being treated but in follow-up).
Exclusion criteria
Exclusion criteria: 1. Minors; 2. Patients with acute or secundairy ITP.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. How many patients need a treatment for chronic ITP; 2. Does the treatment work in non-selected patient group with chronic ITP; 3. What is the frequency and severity of side effects induced by new drugs in a non-selected patients group with chronic ITP; 4. What is the cost-effectiveness. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. | — |
Contacts
Public ContactR. Fijheer
P.O.Box 1502
Outcome results
None listed